Amarin Corporation News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

27.03.17	Drug Makers Stocks Under Scanner -- Teva Pharma, Endo, Ionis Pharma, and Amarin (PR Newswire)
14.02.17	Drug Makers Stocks Under Scanner -- Teva Pharma, Endo, Ionis Pharma, and Amarin (PR Newswire)
06.02.17	The Biotech Market Grows as Demand for New Therapeutics Increases (PR Newswire)
06.01.17	Drug Makers Stocks on Investors' Radar -- Teva Pharma, Endo, Amarin, and Ionis Pharma (PR Newswire)
01.09.16	CYNA Snapped Up For $624 Mln, AMRN On Track, Genmab Gets FDA Nod (RTTNews)
11.08.16	Amarin Posting Steep Loss In Afternoon Trading (RTTNews)
16.09.14	Amarin Reaffirms Commitment To Complete REDUCE-IT Cardiovascular Outcomes Study (RTTNews)
01.04.14	Adherex At ASCO, FDA Panel Backs CBST, DRTX, PRAN's IMAGINE Fails, SKBI Shines (RTTNews)
31.03.14	Amarin In Co-Promotion Deal With Kowa For U.S. Sales Of Vascepa Capsules (RTTNews)
21.02.14	FDA Awards Amarin 3-Yr Exclusivity For Vascepa Capsules (RTTNews)
21.01.14	Amarin Reports FDA Response To ANCHOR SPA Agreement Reinstatement Request (RTTNews)
16.12.13	Amarin Appoints John Thero As President And CEO - Quick Facts (RTTNews)
22.10.13	Amarin To Eliminate 50% Of Its Staff (RTTNews)
17.10.13	Pre-market Movers For Oct 17 (GS, VZ, PACT, AMRN, EBAY, SCSS) (RTTNews)
17.10.13	AMRN Gets Thumbs Down, WMGI Opens Wallet, HBIO To Spin Off HART (RTTNews)
17.10.13	Amarin Says FDA Panel Rejects Vascepa Capsules (RTTNews)
15.10.13	Under AAAResearchReports.com Microscope: Amarin Corp. PLC, Elan Corp. PLC, Seattle Genetics Inc., and Cubist Pharma Inc. (PR Newswire)
14.10.13	Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Amarin Corporation plc (PR Newswire)
09.10.13	Product Development Strategies, FDA Approval, Incremental Agreement, New Clinical Studies, and Other Announcements - Research Report on Amarin, Discovery Labs, Auxilium, Novavax, and Accuray (PR Newswire)
04.10.13	AMRN Faces FDA Panel On Oct.16, Isis Pockets $2Mln, NEOG Effects Stock Split (RTTNews)
30.09.13	Product Launches, Clinical Study Results, Historical Trials, Joint Lawsuits and Milestone Patient Enrollment - Research Report on Teva, Pacira, Novo Nordisk, Forest, and Amarin (PR Newswire)
27.09.13	Beginning New Clinical Trials, Innovation Recognitions, Expansion in Patent Portfolios, Product Distributions and Offerings - Research Report on Allscripts, Novavax, Amarin, Acura, and Catalyst (PR Newswire)
17.09.13	NDA Updates, Signed Agreements, Awarded Patents, and Clinical Study Results - Research Report on Merck, Bristol-Myers Squibb, Amarin, GlaxoSmithKline, and Sanofi (PR Newswire)
16.09.13	Pre-Market Analysis: Amarin Corp. PLC, Elan Corp. PLC, Cubist Pharmaceuticals Inc., and Seattle Genetics Inc. (PR Newswire)
29.08.13	Clinical Trials, Pipeline Developments, Financial Results, and New Appointments - Research Report on Amarin, Immunomedics, Seattle Genetics, Repros Therapeutics, and LifePoint (PR Newswire)
26.08.13	HealthCare, Technology Briefing: Market Movers for the Week - Technologies-Scan Corp, GNC, Galena Biopharma, Immunomedics, Amarin (PR Newswire)
19.08.13	Critical Alerts For Microsoft, Amarin, Regeneron Pharmaceuticals, Best Buy, and Harley Davidson Released By InvestorsObserver (PR Newswire)
08.08.13	Today's Research: Elan Corp. PLC, Amarin Corp. PLC, Seattle Genetics Inc., and Cubist Pharmaceuticals Inc. (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

UBS Group	28.46	2.63 %	K V
Swiss Life Hldg	712.60	1.86 %	K V
Part Grp Hldg	1’245.50	1.26 %	K V
Zurich Insur Gr	545.00	1.15 %	K V
Swiss Re	132.70	1.14 %	K V
Givaudan	3’945.00	-0.53 %	K V
Geberit	511.20	-0.66 %	K V
Alcon	76.38	-0.68 %	K V
Sika	212.90	-1.34 %	K V
CieFinRichemont	134.25	-2.65 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Amarin Corporation PLC (spons. ADRs)

Aktien Top/Flop

Meistgelesene Nachrichten